Risks and side effects of the use of anorectics in women in the state of São Paulo
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2021 |
| Outros Autores: | , , , |
| Tipo de documento: | Artigo |
| Idioma: | por |
| Título da fonte: | Research, Society and Development |
| Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/21005 |
Resumo: | Obesity is a disease that is currently one of the biggest nutritional problems that can lead to the development of several health injuries. The treatment of the disease consists in the change of daily and eating habits or, in some cases, using anorectics. These medications, in addition to treating obesity, are also related to factors such as body dissatisfaction and the standards imposed by society about women’s appearance. This study aims to evaluate and understand the main risks and side effects of the use of the anorectics in women in the state of São Paulo. The method for the development of the present article was through scientific articles on platforms such as Scientific Electronic Library Online (SciELO), PubMed, Academic Google and Science Direct, and the use of online questionnaire disclosed through social media, which obtained 217 responses. When evaluated the use of anorectics and their conditions of use, it was noticed that the most sought drug was sibutramine with 41,94%. It was also observed that there was a low adherence to the pharmacological treatment associated to physical activity and dietary changes. Most interviewed women presented side effects such as nauseas, headache, diarrhoea, mood swings and dry mouth. And 47,50% of the participants did not received professional monitoring, which demonstrates the lack of knowledge regarding the risks of anorectic drugs, since 23,04% see it as a way of quick weight loss. |
| id |
UNIFEI_18488fe298e90d39f1113cc7b473cf41 |
|---|---|
| oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/21005 |
| network_acronym_str |
UNIFEI |
| network_name_str |
Research, Society and Development |
| repository_id_str |
|
| spelling |
Risks and side effects of the use of anorectics in women in the state of São PauloRiesgos y efectos colaterales del uso de anorexígenos en mujeres del estado de São PauloRiscos e efeitos colaterais do uso de anorexígenos em mulheres no estado de São PauloAnorexígenosTratamentoObesidadeMulheresRisco.AnorecticTreatmentObesityWomenRisk.AnorexígenosTratamientoObesidadMujeresRiesgo.Obesity is a disease that is currently one of the biggest nutritional problems that can lead to the development of several health injuries. The treatment of the disease consists in the change of daily and eating habits or, in some cases, using anorectics. These medications, in addition to treating obesity, are also related to factors such as body dissatisfaction and the standards imposed by society about women’s appearance. This study aims to evaluate and understand the main risks and side effects of the use of the anorectics in women in the state of São Paulo. The method for the development of the present article was through scientific articles on platforms such as Scientific Electronic Library Online (SciELO), PubMed, Academic Google and Science Direct, and the use of online questionnaire disclosed through social media, which obtained 217 responses. When evaluated the use of anorectics and their conditions of use, it was noticed that the most sought drug was sibutramine with 41,94%. It was also observed that there was a low adherence to the pharmacological treatment associated to physical activity and dietary changes. Most interviewed women presented side effects such as nauseas, headache, diarrhoea, mood swings and dry mouth. And 47,50% of the participants did not received professional monitoring, which demonstrates the lack of knowledge regarding the risks of anorectic drugs, since 23,04% see it as a way of quick weight loss.La obesidad es una patología que em la actualidad presenta uno de los mayores problemas nutricionales, que pueden conducir al desarollo de varias lesiones a la salud. El tratamiento de esta consiste en cambiar los hábitos alimeticos y diarios, en algunos casos, utilizar medicamento anorexígenos. Estas drogas, además de tratar la obesidade, también están relacionados con factores como la insatisfacción corporal, y los estándares impuestos por la sociedad sobre la apariencia de las mujeres. El estudio tiene como objetivo evaluar y comprender los principales riesgos y efectos colaterales del uso dos anorexígenos en mujeres del Estado de São Paulo. El método para el desarrollo del presente artículo fue a través de artículos científicos en plataformas como Scientific Eletronic Library Online (SciELO), PubMed, Google Acadêmico y Science Direct, además de utilización de un cuestionario online que se difunde en las redes sociales, el cual obtuvo 217 respuestas. Al evaluar el uso de anorexígenos y sus condiciones de uso, se notó que el fármaco más buscado fue la sibutramina con 41,94%. También se observo uma baja adherencia en la asociación del tratamiento farmacológico con la actividad física y los cambios dietéticos. La mayoría de las mujeres entrevistadas presentaron efectos adversos como náuseas, dolor de cabeza, diarrea, cambios de humor y boca seca. Y el 47,50% de las participantes no recibió seguimiento profesional, lo que demuestra el desconocimiento sobre los riesgos de los anorexígenos, ya que el 23,04% lo ve como una forma de pérdida de peso rápida.A obesidade é uma patologia que atualmente apresenta um dos maiores problemas nutricionais podendo acarretar no desenvolvimento de diversas injurias à saúde. O tratamento desta consiste na mudança de hábitos diários e alimentares ou, em alguns casos, no uso de medicamentos anorexígenos. Esses medicamentos, além do tratamento da obesidade, também estão relacionados a fatores como a insatisfação corporal e dos padrões impostos pela sociedade sobre a aparência das mulheres. O estudo tem como objetivo avaliar e compreender os principais riscos e efeitos colaterais do uso dos anorexígenos em mulheres no estado de São Paulo. O método para o desenvolvimento do presente artigo deu-se através de artigos científicos em plataformas como Scientific Electronic Library Online (SciELO), PubMed, Google Acadêmico e Science Direct, além da utilização de questionário online sendo divulgado pelas mídias sociais que obteve 217 respostas. Ao ser avaliada a utilização dos anorexígenos e suas condições de uso percebeu-se que o medicamento mais procurado foi a sibutramina com 41,94%. Foi também observado uma baixa adesão da associação do tratamento farmacológico com atividades físicas e mudanças alimentícias. A maioria das mulheres entrevistadas apresentaram efeitos adversos, tais como náuseas, dor de cabeça, diarreia, mudanças de humor e boca seca. E 47,50% das participantes não obtiveram acompanhamento profissional, o que demonstra a falta de conhecimento perante aos riscos dos anorexígenos, uma vez que 23,04% veem como uma forma de emagrecimento rápido.Research, Society and Development2021-10-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2100510.33448/rsd-v10i13.21005Research, Society and Development; Vol. 10 No. 13; e62101321005Research, Society and Development; Vol. 10 Núm. 13; e62101321005Research, Society and Development; v. 10 n. 13; e621013210052525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/21005/18664Copyright (c) 2021 Thamires Maria de Macedo da Cunha; Vitória Maria Branco Sestito; Isabella Oliveira Campanha; Kerolaine Ladeia Moreira; Gustavo José Vasco Pereirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCunha, Thamires Maria de Macedo daSestito, Vitória Maria BrancoCampanha, Isabella OliveiraMoreira, Kerolaine LadeiaPereira, Gustavo José Vasco2021-11-21T18:26:28Zoai:ojs.pkp.sfu.ca:article/21005Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:40:30.679954Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
| dc.title.none.fl_str_mv |
Risks and side effects of the use of anorectics in women in the state of São Paulo Riesgos y efectos colaterales del uso de anorexígenos en mujeres del estado de São Paulo Riscos e efeitos colaterais do uso de anorexígenos em mulheres no estado de São Paulo |
| title |
Risks and side effects of the use of anorectics in women in the state of São Paulo |
| spellingShingle |
Risks and side effects of the use of anorectics in women in the state of São Paulo Cunha, Thamires Maria de Macedo da Anorexígenos Tratamento Obesidade Mulheres Risco. Anorectic Treatment Obesity Women Risk. Anorexígenos Tratamiento Obesidad Mujeres Riesgo. |
| title_short |
Risks and side effects of the use of anorectics in women in the state of São Paulo |
| title_full |
Risks and side effects of the use of anorectics in women in the state of São Paulo |
| title_fullStr |
Risks and side effects of the use of anorectics in women in the state of São Paulo |
| title_full_unstemmed |
Risks and side effects of the use of anorectics in women in the state of São Paulo |
| title_sort |
Risks and side effects of the use of anorectics in women in the state of São Paulo |
| author |
Cunha, Thamires Maria de Macedo da |
| author_facet |
Cunha, Thamires Maria de Macedo da Sestito, Vitória Maria Branco Campanha, Isabella Oliveira Moreira, Kerolaine Ladeia Pereira, Gustavo José Vasco |
| author_role |
author |
| author2 |
Sestito, Vitória Maria Branco Campanha, Isabella Oliveira Moreira, Kerolaine Ladeia Pereira, Gustavo José Vasco |
| author2_role |
author author author author |
| dc.contributor.author.fl_str_mv |
Cunha, Thamires Maria de Macedo da Sestito, Vitória Maria Branco Campanha, Isabella Oliveira Moreira, Kerolaine Ladeia Pereira, Gustavo José Vasco |
| dc.subject.por.fl_str_mv |
Anorexígenos Tratamento Obesidade Mulheres Risco. Anorectic Treatment Obesity Women Risk. Anorexígenos Tratamiento Obesidad Mujeres Riesgo. |
| topic |
Anorexígenos Tratamento Obesidade Mulheres Risco. Anorectic Treatment Obesity Women Risk. Anorexígenos Tratamiento Obesidad Mujeres Riesgo. |
| description |
Obesity is a disease that is currently one of the biggest nutritional problems that can lead to the development of several health injuries. The treatment of the disease consists in the change of daily and eating habits or, in some cases, using anorectics. These medications, in addition to treating obesity, are also related to factors such as body dissatisfaction and the standards imposed by society about women’s appearance. This study aims to evaluate and understand the main risks and side effects of the use of the anorectics in women in the state of São Paulo. The method for the development of the present article was through scientific articles on platforms such as Scientific Electronic Library Online (SciELO), PubMed, Academic Google and Science Direct, and the use of online questionnaire disclosed through social media, which obtained 217 responses. When evaluated the use of anorectics and their conditions of use, it was noticed that the most sought drug was sibutramine with 41,94%. It was also observed that there was a low adherence to the pharmacological treatment associated to physical activity and dietary changes. Most interviewed women presented side effects such as nauseas, headache, diarrhoea, mood swings and dry mouth. And 47,50% of the participants did not received professional monitoring, which demonstrates the lack of knowledge regarding the risks of anorectic drugs, since 23,04% see it as a way of quick weight loss. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-10-04 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/21005 10.33448/rsd-v10i13.21005 |
| url |
https://rsdjournal.org/index.php/rsd/article/view/21005 |
| identifier_str_mv |
10.33448/rsd-v10i13.21005 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/21005/18664 |
| dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Research, Society and Development |
| publisher.none.fl_str_mv |
Research, Society and Development |
| dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 13; e62101321005 Research, Society and Development; Vol. 10 Núm. 13; e62101321005 Research, Society and Development; v. 10 n. 13; e62101321005 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
| instname_str |
Universidade Federal de Itajubá (UNIFEI) |
| instacron_str |
UNIFEI |
| institution |
UNIFEI |
| reponame_str |
Research, Society and Development |
| collection |
Research, Society and Development |
| repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
| repository.mail.fl_str_mv |
rsd.articles@gmail.com |
| _version_ |
1797052691368640512 |